Institutional Manager · CIK 0001440771
Stonepine Capital Management, LLC
Bend, OR · File #028-17175
Latest AUM
$137.0M
Positions
66
Top-10 Concentration
54.5%
Filings
14
Sector Allocation
Filing History
View all filings →- 13F HOLDINGS REPORTQ/E Dec 202566 pos · $137.0M
- 13F HOLDINGS REPORTQ/E Sep 202558 pos · $123.0M
- 13F HOLDINGS REPORTQ/E Jun 202559 pos · $101.9M
- 13F HOLDINGS REPORTQ/E Mar 202566 pos · $102.8M
- 13F HOLDINGS REPORTQ/E Dec 202452 pos · $123.9M
- 13F HOLDINGS REPORTQ/E Sep 202438 pos · $158.2M
- 13F HOLDINGS REPORT (Amended)Q/E Jun 202425 pos · $109.6M
- 13F HOLDINGS REPORTQ/E Jun 202425 pos · $108.9M
- 13F HOLDINGS REPORTQ/E Mar 202420 pos · $126.1M
- 13F HOLDINGS REPORTQ/E Dec 202323 pos · $301.0M
- 13F HOLDINGS REPORT (Amended)Q/E Sep 20232 pos · $11.0M
- 13F HOLDINGS REPORTQ/E Sep 202319 pos · $266.2M
- 13F HOLDINGS REPORTQ/E Jun 202322 pos · $298.2M
- 13F HOLDINGS REPORTQ/E Mar 202319 pos · $237.7M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | VERASTEM INC | VSTM | 2,732,079 | $21.1M | 15.82% |
| 2 | ADMA BIOLOGICS INC | ADMA | 740,000 | $13.5M | 10.13% |
| 3 | EVOLUS INC | EOLS | 1,631,588 | $10.9M | 8.14% |
| 4 | ZEVRA THERAPEUTICS INC | ZVRA | 569,088 | $5.1M | 3.83% |
| 5 | INHIBIKASE THERAPEUTICS INC | IKT | 2,348,147 | $4.8M | 3.61% |
| 6 | ABEONA THERAPEUTICS INC | ABEO | 709,505 | $3.7M | 2.81% |
| 7 | NEKTAR THERAPEUTICS | NKTR | 85,000 | $3.6M | 2.70% |
| 8 | INDIVIOR PLC | INDV | 100,000 | $3.6M | 2.69% |
| 9 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 389,916 | $3.2M | 2.38% |
| 10 | KAZIA THERAPEUTICS LTD | KZIA | 460,359 | $3.2M | 2.38% |
| 11 | XOMA ROYALTY CORPORATION | XOMAP | 115,000 | $3.1M | 2.29% |
| 12 | VERRICA PHARMACEUTICALS INC | VRCA | 353,669 | $2.9M | 2.20% |
| 13 | CYBIN INC | HELP | 339,902 | $2.8M | 2.09% |
| 14 | TELA BIO INC | TELA | 2,352,032 | $2.8M | 2.08% |
| 15 | ACADIA PHARMACEUTICALS INC | ACAD | 100,000 | $2.7M | 2.00% |
| 16 | CRISPR THERAPEUTICS AG | CRSP | 50,000 | $2.6M | 1.97% |
| 17 | SURROZEN INC | SRZNW | 113,631 | $2.6M | 1.93% |
| 18 | ALEXANDRIA REAL ESTATE EQ IN | 015271109 | 50,000 | $2.4M | 1.84% |
| 19 | X4 PHARMACEUTICALS INC | XFOR | 593,573 | $2.4M | 1.78% |
| 20 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 100,000 | $2.3M | 1.73% |